What have we learned after four randomized controlled trials on neoadjuvant chemotherapy for ovarian cancer?
Journal
International Journal of Gynecological Cancer
Journal Volume
31
Journal Issue
4
Pages
642-643
Date Issued
2021
Author(s)
Batista T.P.
Subjects
cytoreduction surgical procedures; ovarian neoplasms
Other Subjects
BRCA1 protein; BRCA2 protein; advanced cancer; aggression; cancer chemotherapy; cancer prognosis; cancer survival; comorbidity; cytoreductive surgery; emergency health service; female; gene mutation; human; multimodality cancer therapy; neoadjuvant chemot
Publisher
BMJ Publishing Group
Type
note